Matteo Mombelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Matteo Mombelli has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Manuel Pascual
Transplantation Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
5 shared publications- Christian van Delden
Transplant Infectious diseases Unit, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland
4 shared publications - Dionysios Neofytos
Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland
4 shared publications Oriol Manuel
Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland
4 shared publications- Oriol Manuel
Infectious Diseases Service Lausanne University Hospital and University of Lausanne Lausanne Switzerland
4 shared publications Christian Garzoni
Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland
3 shared publications
Latest Publications
- 22 December 2021
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 20 (5) , 663-680
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review
In solid organ transplant (SOT) recipients, viral infections are associated with direct morbidity and mortality and may influence long-term allograft outcomes. Prevention of viral infections by vaccination, antiviral prophylaxis, and behavioral measures is therefore of paramount importance. We searched Pubmed to select publications to review current preventive strategies against the most important viral infections in SOT recipients, including SARS-CoV-2, influenza, CMV and other herpesvirus, viral hepatitis, measles, mumps, rubella, and BK virus. The clinical significance of the reduced humoral response following mRNA SARS-CoV-2 vaccines in SOT recipients still needs to be better clarified, in particular with regard to the vaccines’ efficacy in preventing severe disease. Although a third dose improve immunogenicity and is already integrated into routine practice in several countries, further research is still needed to explore additional interventions. In the upcoming years, further data are expected to better delineate the role of virus-specific cell mediated immune monitoring for the prevention of CMV and potentially other viral diseases, and the role of the letermovir in the prevention of CMV in SOT recipients. Future studies including clinical endpoints will hopefully facilitate the integration of successful new influenza vaccination strategies into clinical practice.
- 22 December 2021
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 20 (5) , 663-680
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review
In solid organ transplant (SOT) recipients, viral infections are associated with direct morbidity and mortality and may influence long-term allograft outcomes. Prevention of viral infections by vaccination, antiviral prophylaxis, and behavioral measures is therefore of paramount importance. We searched Pubmed to select publications to review current preventive strategies against the most important viral infections in SOT recipients, including SARS-CoV-2, influenza, CMV and other herpesvirus, viral hepatitis, measles, mumps, rubella, and BK virus. The clinical significance of the reduced humoral response following mRNA SARS-CoV-2 vaccines in SOT recipients still needs to be better clarified, in particular with regard to the vaccines’ efficacy in preventing severe disease. Although a third dose improve immunogenicity and is already integrated into routine practice in several countries, further research is still needed to explore additional interventions. In the upcoming years, further data are expected to better delineate the role of virus-specific cell mediated immune monitoring for the prevention of CMV and potentially other viral diseases, and the role of the letermovir in the prevention of CMV in SOT recipients. Future studies including clinical endpoints will hopefully facilitate the integration of successful new influenza vaccination strategies into clinical practice.
- Open Access
- 12 September 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (1) , 199-209
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients
- 12 September 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (1) , 199-209
Open AccessEpidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients
- 1 September 2021
- Published by Elsevier in Journal of Infection
- Vol. 83 (3) , 354-360
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial
- 1 September 2021
- Published by Elsevier in Journal of Infection
- Vol. 83 (3) , 354-360
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial
- Open Access
- 2 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (7) , 2532-2542
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
- 2 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (7) , 2532-2542
Open AccessAssociation of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
- Open Access
- 31 October 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1789-1800
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
- 31 October 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1789-1800
Open AccessBurden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
- Open Access
- 15 May 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2876-2882
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
- 15 May 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2876-2882
Open AccessFirst experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
- Open Access
- 25 November 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (5) , 1424-1430
Real-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients
- 25 November 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (5) , 1424-1430
Open AccessReal-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients